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Progress has been made in understanding the molecularmechanisms that regulate cell type-specific gene
expression during the terminal differentiation ofcells into specialized tissue types. These studies have con-
centrated largely on defining the cis elements and trans-acting factors responsible for the transcription of
differentiation-specific genes. Valuable as these investigations have been, they have not been able to place
differentiation intothe largercontextofdevelopment, specifically intothecontextoftheearlierdevelopmental
process ofcell deternination, when embryonic stem cell lineages are forned andthe genetic regulatory pro-
grams for cell type-specific gene activation and expression are acquired by stem cells.
The clonal mouseembryocell line, C3H/10T1/2, clone 8(1OT1/2) provides a unique opportunity to examine
the molecular genetic requlation ofboth the developmental determination ofvertebrate stem cell lineages
and their subsequent differentiation. 1OT1/2 is an apparently multipotential cell line that can be converted
by5-azacytidine intothree mesodermal stem cell lineages. These detenninedproliferative stem cellsare sta-
ble inculture andretain theirability to differentiate inmitogen-depleted medium. The most significantdis-
covery has been that 1OT1/2 lineage deternination is under simple genetic control and that the regulatory
genes thatmediate theformation ofmyogeniccell lineages, andlikelythe chondrogenic andadipogenic line-
ages, can be demonstrated and studied by genomic DNA and cDNA transfection approaches. This paper is
a description ofthe remarkable properties and genetic behaviors ofthe 1OT1/2 cells and a discussion ofthe
insights that future studies ofthis cell may provide.
Mesodermal Differentiation and
Oncogenic Transformation
1OT1/2 cells are aclonal celllineestablishedandcharac-
terizedby Reznikoffetal. (1). They were derivedfrom 14-
to 17-day C3H whole mouse embryos, so their tissue of
originisunknown. The cell line was established usingthe
method ofAaronsen and Ibdaro(2), which selectsforcells
that are sensitive to postconfluence inhibition ofcell di-
vision. These cells maintain a stable morphology even af-
ter longperiods in culture. When subconfluent, they ap-
pear fibroblastlike with extended cytoplasmic processes.
In confluent cultures, thecellsform aflat, regular, epithe-
lioidlike sheet. The modal chromosome number is stable
at81, whichishypertetraploidformice. Expressionof C-
type retroviruses could not be detected over large pas-
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sage numbers, and the cells were not tumorigenic when
injectedinto irradiatedandnonirradiated C3H mice. The
presence and consistency of these characteristics make
this cell lineideally suitedfor studies ofmalignant trans-
formation in vitro by a variety of chemical and viral
agents.
Duringone such studyofmalignant transformationby
the S-triazine nucleoside analogue of cytidine,
5-azacytidine (5-Aza-CR), which is used as a cancer
chemotherapeutic agent, Constantinides et al. (3) ob-
served elongated, multinucleated cells that morphologi-
callyresembledmyofibers. Furtherinvestigation showed
that the multinucleated cells expressed biochemical
properties of muscle so that they could contract when
treated withacetylcholine (3), hadreceptors toacetylcho-
line capable of binding a-bungarotoxin, and a calcium-
dependent (myosin) ATPase (4). Consistent with these
results, otherresearchers demonstrated thepresence of
an array ofmuscle-specific contractile proteins synthe-
sized by 5-Aza-CR-derived myofibers (5,6). Thus, 1OT1/2
cells can differentiate and form muscle after treatment
with 5-Aza-CR.PINNEYAND EMERSON
Alaterreportby TaylorandJones(7) showedthattwo
other mesodermal phenotypes, adipocytes and chondro-
cytes, were expressed by 1OT1/2 cells after treatment
with 5-Aza-CR at an optimal concentration identical to
thatwhichresulted inthe formation ofmyofibers. There
was atemporal orderofappearance ofthethree differen-
tiated phenotypes; myofibers appeared 5 to 6 days after
the treated cells had reached confluence, followed by
adipocytes about 4 dayslater, andfinally chondrocytes in
9 to 16 days more. In the case ofmyofibers and chondro-
cytes, the relative order ofappearance is consistent with
that observed in developing chicken limb buds (8), sug-
gesting that the developmental timing ofdifferentiation
is preserved in this cell line following 5-Aza-CR treat-
ment.
Adipocytes have a morphology typical ofmultilocular
fat cells andcanbe stainedwithoil Red-O(7). To confirm
the identity ofthisphenotype, TaylorandJones(7)meas-
ured the accumulation oftriglycerides and the activities
of two key enzymes offatty acid synthesis, ATP-citrate
lyase and acetyl-CoA carboxylase. Consistent with their
evidence, Chapman et al. (9) later showed that an addi-
tional enzyme activity typical ofmature adipocytes, gly-
cerophosphate dehydrogenase, increased 100-fold and that
lipoprotein lipase couldbe detectedimmunologically in adi-
pocytes derived from 1OT1/2 cellsby5-Aza-CRtreatment.
The cartilage cellsobservedwere seenintightlypacked
foci ofpolygonal cells (7). These cells showed metachro-
matic staining with toluidine blue and incorporation of
"S-sulfate, both ofwhichwerereducedwithdigestionus-
ingchondroitinase ABC. Theseresults suggested thatthe
cells synthesized sulfated proteoglycans that are associ-
ated with the extracellular matrix of cartilage. In addi-
tion, these fociofcellsbound antibodyagainsttype II col-
lagen (7).
In addition to the mesodermal phenotypes observed,
Benedict et al. (10) described low frequency (1.75%) on-
cogenic transformation of1OT1/2 cells by 5-Aza-CR. The
transformed cells had an altered morphology, formed
typical type III transformed foci, and formed tumors
when injected into immunosuppressed syngeneic mice.
The appearance ofthis additional nonmesodernal pheno-
type suggests that 5-Aza-CR acts on specific targets, in
this case oncogenes, rather than changing the general
state ofcells, forcingthem into apresetmesodermal pro-
gram. In addition to 5-Aza-CR, 1OT1/2 cells canbe trans-
formedwith avariety ofothertumorigenicagents, result-
ingin celllines(11,12). Two oftheselinesweresubeloned
(7)andtreatedwith5-Aza-CR andscoredformyofiberfor-
mation. Both cell lines testedgaverise tomultinucleated
cells with the same 5-Aza-CR concentration dependency
asparental 1OT1/2 cellsbutresultedin amuch lowerfre-
quency ofmyofiber formation. Again, these results sug-
gestaspecificityof5-Aza-CR actionanddemonstrate that
the transformedphenotype does notpreclude the appear-
ance of at least the myogenic phenotype.
Although adipocytes, myofibers, andchondrocytes are
all mesodermal in origin, amultipotential precursor cell
has neverbeen isolatedinprimaryculture thatgives rise
to all three differentiatedphenotypes. However, there is
furtherevidencefor a commonmesodermalprecursor cell
using other cloned cell lines that can significantly be in-
duced to express these differentiated phenotypes follow-
ing treatment with 5-Aza-CR. Taylor and Jones demon-
stratedthat Swiss3T3 cells, anestablishedfibroblastlike
cell line derived from mouse embryos, give rise to all
three phenotypes after treatment with 5-Aza-CR in a
concentration-dependent manner, but at lower frequen-
cies than 1OT1/2 cells (7). In addition, these same re-
searchers showed that an adult mouse prostate cell line,
CVP3SC6, also gave rise to adipocytes, myofibers, and
chondrocytes when treated with comparable concentra-
tions of5-Aza-CR, although at significantly reduced fre-
quencies compared to the embryo cell lines (13). There-
fore, there is reason to propose that 1OT1/2 represents a
typical mesodermal multipotential cell and that the
results of5-Aza-CR treatmentreflect an authenticmech-
anism regulating the expression of the mesodermal
phenotypes.
Determination into Stable Stem
Cell Lineages
The analyses reportedthus faradequately demonstrate
that 1OT1/2 cells can differentiate into specialized cell
types followingtreatment with 5-Aza-CR. However, ter-
minal differentiationis anendpoint assay and cannot by
itselfaddress the question ofwhich developmental deci-
sionsarebeingmade asaresultof5-Aza-CR. Arethecells
being converted directly from fibroblastlike, apparently
undifferentiated, parental cells into muscle, fat, and car-
tilage cells so thatthe phenotypicgenes are somehowbe-
inginduced directlybythe chemotherapeutic agent? Or,
are 1OT1/2 cells undergoing a process that more closely
resemblestheinvivo situation sothat5-Aza-CR converts
1OT1/2 cellsinto determined stem cellsthatcanprolifer-
ate and then differentiate, expressing their unique cell-
type specific proteins?
Konieczny and Emerson(5)undertook aclonal analysis
of 5-Aza-CR treated 1OT1/2 cells to determine whether
the cells were bypassing determination or were in fact
proceeding through the entire developmental program.
1OT1/2 clonal cultures were treated with 5-Aza-CR, and
multiple colonies containing cells of each differentiated
phenotype were recloned and expanded.
Proliferative cellsfrom the adipogeniclinesmorpholog-
icallyresembled 1OT1/2cells, whereascellsfromthemyo-
geniccloneswerebipolar, small, andhighlyrefractile, and
cells from the chondrogenic clones appeared polygonal.
The clonal populations were allowed to reach confluence
and examined for differentiated cells. In every case, the
clonal cell lines isolated differentiated into only the sin-
gle selected celltype. Two-dimensionalproteingel analy-
ses showedthatspecificproteinspresentin 10T1/2cell ex-
tracts were missing from the myogenic, adipogenic, and
chondrogenic celllinesexamined. Inaddition, atleastone
majorproteinappearedtobeunique tothemyogeniccell
lines. Most significantly, muscle-specific contractile pro-
teins couldnotbe detectedinextractsfromproliferative
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cultures of the myogenic cell lines, whereas fusing cul-
turesexhibitedthefull spectrumofdifferentiation-specific
proteins. These results showed that, following 5-Aza-CR
treatment, cells ofeachphenotype arose thatsynthesized
sets ofproteins that were different than those expressed
by 1OT1/2 cells, the other mesodermal phenotypes, and
the end point-differentiated cells. These cells were
proliferative, stable, and capable ofdifferentiation under
appropriate culture conditionsoflowmitogen stimulation.
Thus, these studies showedthat5-Aza-CR didnot directly
activate differentiation-specific genes but rather con-
verted the cells into determined stem cell lineages capa-
ble of differentiating in the appropriate environment.
Consistent with the clonal and protein analyses of
Konieczny and Emerson, Chapman et al. performed a
cDNA analysis ofan adipocyte clone derivedfrom 1OT1/2
cells by 5-Aza-CR (9). These researchers constructed a
cDNA library from a fully differentiated adipocyte line
and, usingdifferential screeningtechniques, characterized
three classes of RNAs: a) RNAs that are absent in un-
treated 1OT1/2 cellsandpreadipocytesbutareexpressed
by adipocytes; b) RNAs that are present at low levels in
1OT1/2 cells and inpreadipocytes and increase 3- to 4-fold
or 10- to 20-fold in adipocytes; and c) aunique RNA that
is 4-fold more abundant in preadipocytes than in 1OT1/2
cells andundergoes anadditional 6-foldincrease in adipo-
cytes. The expression of several other RNAs decreased
during adipogenic conversion. Their results reiterate at
the RNAlevel the individual identities ofthe 1OT1/2cells,
proliferative determined stem cells, and the differentiated
phenotypic cells.
Further evidence that 5-Aza-CR is not directly activat-
ingmuscle-specific contractile proteingenes wasprovided
by DNA transfection experiments. 1OT1/2 cells and a
previously characterized myogenic cell line derived from
1OT1/2 cells were stably transfected with aquail skeletal
troponin I (ThI)gene (14). Neither the quailThI gene nor
the endogenous mouse skeletal a-actin gene was ex-
pressed inparental 1OT1/2 cells, a myoblast line derived
from the transfected 1OT1/2 cellsby5-Aza-CRtreatment,
or the proliferative myogenic cell line. In contrast, these
genes were expressed in fusing cultures ofthe myogeni-
cally converted, transfected 1OT1/2 cells andthemyogenic
cell line. Similarresults were obtained when 1OT1/2 cells
and a 5-Aza-CR-derived myogenic cell line were stably
transfected with achicken cardiac a-actingene(6). These
resultsprovedthat5-Aza-CRisnot directly affectingcon-
tractileproteingenes; the exogenously addedgenes were
not expressed inproliferative cells even when theywere
introduced prior to 5-Aza-CR, but the genes were ex-
pressed by fusing cells even when they were introduced
longafterthe cell lines hadbeenestablisbedby5-Aza-CR
treatment. The transfected genes were activated ap-
propriately, both temporally andquantitatively, infusing
myofibers, suggesting that they are responsive to the
regulatory mechanisms operating in cells converted by
treatment with 5-Aza-CR. Therefore, these experiments
suggest that 5-Aza-CR isinvolved inestablishing thereg-
ulatory program that controls the expression of the
differentiation-specific genes.
It is evident from the work reported that 5-Aza-CR
treatment of1OT1/2 cells canresultin the establishment
of distinct cell lines that fulfill the criteria ofbeing sta-
bly determined, proliferative stem cell lines capable of
differentiating and expressing their specific phenotypic
genes. Further, the evidence indicates that 5-Aza-CR is
not activating the differentiation-specific genes them-
selves but ratheris inducing a determined state that ac-
tivates a regulatory program capable of responding ap-
propriatelyto environmental signals. In short, itappears
that5-Aza-CRis causingcelldetermination ofcertainline-
ages within 10T1/2 cells so that they at some point must
representmultipotential, mesodermalprecursor cells. It
isnotpossible atthispointto determine whether 10T1/2
cells are actually multipotential orwhether 5-Aza-CR in-
duces an unstable multipotential state.
Conversion of DNA Sequences by
Hypomethylation
Several lines of evidence suggest that 5-Aza-CR con-
verts 10T1/2 cells into determined lineages by causing
hypomethylation of DNA. Jones and Taylor (15) showed
by direct measurements ofDNAmethylation that 5-Aza-
CR at micromolar concentrations is an efficient inhibitor
ofmethylation in 10T1/2 cells. Decreases in methylation
could be correlated with increasing 5-Aza-CR doses and
withincreasingmyofiberformation. Inthese experiments
the optimal concentration of5-Aza-CR for myofiber for-
mation was 2 ,uM, which caused a 62% decrease in cyto-
sine methylation. Additional directmeasurements showed
thatnewly synthesized strandswere significantly under-
methylated when the cells were exposed to 5-Aza-CR for
20 hr and were not remethylated during a subsequent
20-hr period in the absence of 5-Aza-CR.
Consistent with the hypothesis that 5-Aza-CR acts by
causing hypomethylation of DNA, the deoxy analogue,
5-aza-2'-deoxycytidine, causes myofiber formation at the
same frequency but with 1/10 the concentration. Other
analogues of cytidine substituted at the same position
were showntobe effective inhibitors ofDNAmethylation
andalso to cause myofiberformation. Althoughthelevel
ofincorporation of5-Aza-CR reachedonly 5%whenthere
was an 80 to 85% inhibition of methylation, it was
hypothesized that the methylating enzymes walk along
the DNA so that 5-Aza-CR may impede enzyme move-
mentandthereforeinhibitmethylationofadditional sites.
Maximal induction of myofibers and adipocytes was
shown to occur when 1OT1/2 cells were treated with
5-Aza-CR duringearly Sphase(4,13). Incorporationofthe
analogue into DNAwas notenhancedduringthisperiod
ofthe cell cycle andthere were no significant differences
in incorporation into RNA throughout the cell cycle.
Therefore, itwastheorizedthatincorporationof5-Aza-CR
into specific DNA sequences synthesizedduringearly S-
phase is responsible for the conversion events.
Studies of methylation patterns by Bird (16) showed
that both cytosines in a CpGpaired sequence are either
both methylated or both unmethylated, which is consis-
tent with theories thatmethylation patterns are conser-
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vatively replicated (17,18). A model proposed by Jones
and Thylor(13) suggests that 5-Aza-CR wouldperturb the
methylationpatterns in 1OT1/2 DNA and thatthese new
patterns ofmethylationwould become set within the ge-
nome during two DNA replication cycles. This model
wouldpredict the subsequent reports that clonal cultures
of5-Aza-CR treated 1OT1/2 cells contain mixed colonies
ofconverted and parental cells (5) or more than one con-
vertedphenotype (5,13) andwouldpredict the subsequent
segregation and stability of phenotypes (5) following
recloning. Although there has been no direct demonstra-
tion that hypomethylation ofspecific DNAloci by 5-Aza-
CR results in conversion of 1OT1/2 cells, these results
strongly support this mechanism of action.
The highfrequency ofconversion makes the 1OT1/2 cell
line a particularly attractive model system in which to
study determination. In addition, these frequencies sug-
gest amodel thatproposes a simple genetic basis for de-
termination. Taylor and Jones (13) treated single cells
with 5-Aza-CR and examined the expanded cultures for
phenotypic conversion. A total of 62% of the colonies
showed phenotypic conversion with atleast one differen-
tiated cell type(Table 1). Ofthese colonies, 31% contained
myofibers, 8% contained adipocytes, and 2% contained
chondrocytes. In addition, all combinations of differen-
tiatedphenotypes were found inmixed colonies. Surpris-
ingly, mixed muscle and adipocyte colonies comprised
16% of the total, whereas the other mixed phenotypes
were 1 to 2% ofthe total. Konieczny et al. (5,19) treated
cultures of 1OT1/2 cells plated at clonal density with
5-Aza-CR (Table 1). Theyfound that atotal of34% ofthe
colonies contained differentiated cells; 25% ofthe clones
contained myofibers, 7%hadadipocytes, and 1% contained
chondrocytes. An additional 1% ofthe colonies contained
both muscle andfat. Ineach case, the colonies containing
differentiated cells also containedparental 1OT1/2, as did
theremaining66% ofthe colonies. Whenthe colonies with
converted cells wererecloned, the individualphenotypes
segregated. These separate reports show that there is a
highfrequency ofmesodermal determination, especially
myogenic determination. The discrepancies inthe report-
edfrequencies ofmixed colonies have notbeen resolved.
Konieczny et al. proposed amodel to account for these
high frequencies of determination (5). They suggested
Table 1. Phenotypic conversion frequencies of1OT1/2 cellsfollowing
5-azacytidine treatment.




Muscle and adipocyte 16 1
Muscle and chondrocyte 1 0
Adipocyte and chondrocyte 2 0
Muscle, adipocyte, and
chondrocyte 2 0
aTaken fromworkbyTaylorandJones(13). Single cell cultures were
treated with 3,M 5-Aza-CR and atotal of173 survivingcolonies were
examined.
bTaken from work by Konieczny and Emerson (5). Clonal cultures
were treated with 3 IAM 5-Aza-CR and a total of approximately 1500
colonies were examined.
that 1OT1/2 cells were blockedin mesodermal conversion
by DNA methylation of unlinked determination loci.
These loci could have been methylated in the embryonic
cell from which the 1OT1/2 cell line was derived or dur-
ingthe establishment oftheline in culture. Duringearly
S-phase, some of the determination loci would be hemi-
methylated when the cells were treated with 5-Aza-CR.
Duringthe subsequenttwo rounds ofreplication and ran-
dom segregation of chromosomes, the daughter cells
wouldreceive eitherfullyunmethylated sitesattheseloci
ormethylated sitesidentical to parental 1OT1/2 DNA. If
the number ofunmethylated sites were adequate, a de-
termination locuswouldbe activated and aportion ofthe
daughter cells would be converted to the corresponding
new phenotype. Simply correlating the level of
hypomethylation to conversionfrequencies suggests that,
inthe case ofmyogenic conversion, there are only one or
a few determination loci. That is, if DNA methylation
were 60% inhibited in arandommanner atthe concentra-
tionof5-Aza-CR used, 36% ofthe colonieswould contain
myogenic cells, assuming that two unmethylated sites
within the myogenic locus or one site each within two loci
were required for conversion. The lower frequencies of
adipogenic and chondrogenic conversions suggest that
they require correspondingly more unmethylated sites
within a locus or multiple loci. This model is consistent
withthe currenttheories ofDNAmethylation(17,18)and
explains the segregation and stability ofphenotypesfrom
the clonal analysis of 5-Aza-CR treated 1OT1/2 cells.
Myogenic Determination
The establishment of stable clonal cell lines of each
mesodermal lineage following 5-Aza-CR treatment of
1OT1/2 cells suggested a preliminary test of the theory
that determination has a simple genetic basis such that
conversionis causedbythe activationofone or afewreg-
ulatoryloci(5). TransfectedgenomicDNAfromacellwith
an active, presumably hypomethylated, determination lo-
cus should convert 1OT1/2 cells to amesodermal lineage.
Konieczny et al. (19) isolated genomic DNA from a
1OT1/2-derived myoblast cell line and from embryonic
quail myoblasts. Each genomic DNA was cotransfected
with aplasmid containing agene conferringresistance to
the antibiotic G418. In each case, the frequency ofmyo-
genic conversionwas2 x 10-4 G418-resistant cells. In ad-
dition, Lassar et al. (6) demonstrated in a similar trans-
fection experiment that transfection of 1OT1/2 with
genomic DNAs isolated from a 1OT1/2-derived myoblast
cell line or from the mouse C2C12 myoblast cell line
resulted in myogenic conversion frequencies of about
7 x 10 -5 G418-resistant cells. These experiments, al-
though suggestive, are limited in their interpretations.
Since no marker was associated with the transfected
genomic DNA, there was no method to confirm that the
exogenously added DNAs were responsible for the ob-
served conversion events. In fact, Lassar et al. reported
a high frequency of spontaneous conversion (6).
A more direct test ofthe modelhasbeenperformedby
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Pinney et al. (20). Ahuman DNAlibraryclonedinto acos-
mid vectorwas transfected into 1OT1/2 cells and selected
for G418 resistance conferred by a neomycin resistance
(NeoR)genecontainedwithinthe vector. Therationale for
this experiment was that cloned human DNA passaged
through methylase-deficient bacteria would be hypo-
methylated and therefore mesodermal determination
genes may be active when introduced into mammalian
cells. In addition, the NeoR gene would allowtracking of
linked DNAinprimaryand secondarytransfections. The
frequency of myogenic conversion in primary transfec-
tions was 2 x 10- G418 resistant colonies. Considering
the average complexity of cosmid integrations, this fre-
quency showedthat a singlegene was sufficient to cause
myogenic conversion. One ofthemyogenic clones wasiso-
lated as a stable myoblast celllineandgenomic DNAiso-
latedfor secondary transfections. 1OT1/2 cellswere trans-
fectedwith this genomic DNA and selectedforthe NeoR
gene that should remain linked to the myogenic determi-
nationgene. Intwo transfection experiments, two stable
myogenic cell lines were obtained outofatotal of31 G418
resistant colonies. These results prove that a single DNA
locus, mydis sufficient to cause myogenic determination
and, therefore, thatthere is asimplegeneticbasisformy-
ogenic conversion.
Usinganalternative cDNAapproach, Davis etal. have
identified and characterized a gene product that causes
myogenictransformation of1OT1/2 cellswhenthe cDNA
is cloned into an expression vector(21). A cDNAlibrary
was constructedfromamixture ofmyoblastandmyofiber
poly A+ RNA from a 1OT1/2-derived myogenic cell line.
A differential screening approach was used to identify
three clones that were expressedprimarily inproliferat-
ingmyoblasts butwere absent inmyogenic variants that
had reverted to a nonfusing phenotype. One of these
clones, Myo D, is not expressed in confluent, growth-
arrested 1OT1/2 cells and is absent orgreatly reduced in
the nonfusing variant lines.
In contrast, Myo D isexpressedbyproliferative and dif-
ferentiated 1OT1/2-derived myogenic cell lines. Inter-
estingly, Myo D RNAisexpressedinneonatal and adult
mouse skeletal muscle but in none of the other tissues
tested. When clonedinto anexpression vectorunderthe
control ofthe Moloney sarcoma virus LTR, Myo D con-
verts 50% of transfected 1OT1/2 cell colonies as well as
several other mousefibroblast celllines[NIH3T3, Swiss
3T3, Swiss 3T3 clone 2 (C2), L Cells, Swiss 3T3-derived
adipocyte lines (3T3-LI and 3T3-F442A), and a
1OT1/2-derived adipocyte line (TA1)] atfrequencies vary-
ing from 3 to 65%. It is interesting and perhaps signifi-
cant that the adipogenic phenotype, just as the trans-
formed phenotype (7), did not preclude myogenic
conversion. Nomyogenic conversion was observedwhen
a monkey kidney cell line (CV1) was transfected. The
authors noted that the lack of conversion of CV1 cells
could be due to the epithelial, rather than mesodermal,
originofthese cells oraspeciesincompatibility oftheMyo
Dproduct. Thus, a singlegeneproduct can cause conver-
sion of 1OT1/2 cells as well as other embryonic cell lines
ofapparently mesodernal origin even those considered
to be already determined.
Thesetwoexperimental approaches haveyieldedintrig-
uing results and may indicate that a single gene encod-
ing a single gene product is necessary and sufficient to
convert 1OT1/2 cells into a myogenic lineage. Alterna-
tively, ifmydandthe Myo Dgenesarenotidentical, these
separate results may suggest apathway ofgenesinvolved
in myogenic conversion. Thegenomic DNAapproach sug-
gests that the myd locus contains the promoter and any
regulatory elements necessary for expression within the
1OT1/2 cells and that after passage through the bacterial
host the myd locus is in an active state. Further ex-
perimental data are required to conclude that myd is ac-
tivated by hypomethylation or that it is the initiator or
sole regulator ofmyogenic conversion. Similarly, it canbe
inferredthatthe Myo Dproductisanintegralpart ofthe
myogenic conversion process, yet because its expression
is under the control of a heterologous, constitutive pro-
moter, it is unclearwhetherthe Myo Dgene is the cause
or rather is the result ofthe myogenic conversion event.
Ongoing research should be able to address and answer
most of these questions.
Proposed Models of Myogenic
Determination
The studies reviewed in this article provide compelling
evidence that conversion of 1OT1/2 cells into determined
stem cell lineages has a simple genetic basis. In the case
ofmyogenic conversion, determination appears to be con-
trolledby activation ofasingle determinationlocus, which
forthe sake ofdiscussionwillbe calledmyd, probablyby
ahypomethylationmechanism. The activationofthismy-
ogenic determination gene causes profound changes in
gene expression, suggesting thatthemydlocus isrespon-
sible forestablishing anewregulatory program thatmust
include repression of the synthesis of a specific set of
1OT1/2 cell proteins, activation of the synthesis of
myoblast-specificproteins, andpreparationofatranscrip-
tional regulatory program for the differentiation-specific
activation of muscle protein genes.
We can imagine three general mechanisms by which a
myogenic determination gene might establish the regu-
latory changes involved in the myoblast determination
process. Thefirst is amasterregulatorygenemechanism
in which the product ofmyd gene acts directly upon all
three classes of determination-specific genes, i.e., to re-
press 1OT1/2 cell-specific genes, to induce myoblast genes,
andtoprepare atranscriptional control systemforthe ac-
tivation ofmuscle genes (Fig. lA). The second is aparal-
lelregulatorygenepathwaymechanisminwhichmydin-
itiates, and perhaps maintains, a secondary set of
regulatory genes that would, in turn, control the
myoblast-specific processes (Fig. 1B). Athirdpossibility
is a hierarchical pathway model in which myd would in-
duce secondary regulatory genes, which would subse-
quently activate a tertiary set ofmuscle-specific regula-
torygenes (Fig. 1C). In these cases, the function ofsuch
activators ofmuscle proteingenes couldbe regulatedby
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FIGURE 1. Models of myogenic determination.
environmental cues related to concentrations ofgrowth
factors (22,23). Suchgrowthfactorregulation couldbe ac-
complished by a number ofmechanisms such as control
ofthe synthesis andthe levels ofmuscle proteingene ac-
tivators, the formation of transcription complexes with
differentiation-specific regulatory proteins, or the post-
translational modification of these muscle protein gene
transcription activators. Investigation of whether myo-
genic determination geneexpressionisconstantly ortran-
siently required to maintain the myogenic lineage could
help distinguish amongthese mechanisms. Inthisregard,
Davis et al. showed that Myo D is expressed continually
inmyogenically converted celllines andthatlinesthatre-
vertto anonmyogenicphenotype canberescuedbytrans-
fection with Myo D cDNA in an expression vector (21).
Since myogenic determination seemsprimarily to involve
transcriptional control processes, itmaybe thatthe myd
product is atranscription factor. However, itis conceiva-
ble thatmyd couldregulate transcription less directly as
a cell surface receptor or as an intermediate in a signal
transductionpathway. Therefore, discoveringthe nature
ofthemydproduct willprovide valuableinsight into the
exact mechanism involved in establishing myogenic line-
ages.
Significant progress has been made inunderstanding
the molecularmechanisms involved in celllineage deter-
mination anddifferentiationusingthe 1OT1/2 cellline. The
remarkable properties of 1OT1/2 cells suggested models
ofdetennination andthe advantages ofaclonaltissue cul-
ture system have allowed researchers to test these hy-
potheses using DNA transfection approaches. Perhaps
themostoutstandingconclusionreachedisthatadevelop-
mental decision, myogenic determination, is under sim-
ple genetic control andmay primarily involve the estab-
lishment of transcriptional regulatory programs. It is
reasonable to expectthat similarmechanismswillbe dis-
coveredthatregulate the establishment ofadipogenic and
chondrogenic lineages in the 1OT1/2 cell andthat the ap-
proaches usedto investigate myogenic determination can
be applied. Furthermore, the experimental approaches
and findings developed in studies of 1OT1/2 cells offer a
newparadigmforbothinvitro andinvivoinvestigations
ofembryonic determination in a variety ofdifferent em-
bryonic lineages.
We thank Brian Brunk and Patrick Bender for helpful discussions.
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